Two of Fresenius Vamed’s rehabilitation clinics in Austria have again been certified as “World Hospitals” by the Joint Commission International (JCI). The renewed certifications mean the Rehabilitation Clinic Montafon and the Neurological Therapy Center Gmundnerberg remain among the approximately 800 hospitals worldwide recognized by the JCI as top-tier facilities. A certification as a World Hospital is valid for three years. Quality standards are verified annually by the U.S.-based JCI, the world’s leading competence center for quality and patient safety in healthcare.

Ketorolac Tromethamine, a nonsteroidal anti-inflammatory drug, is now available in the company’s Simplist™ ready-to-administer prefilled syringe in the United States. This marks the first new product launch for the Simplist™ line following ownership by Fresenius Kabi.

Daptomycin, an antibiotic, expands Fresenius Kabi's anti-infective Portfolio.

Fresenius Vamed has successfully completed another major project in Germany’s healthcare system, an emergency care center at the Charité university hospital in Berlin. The new center was built in partnership with the construction company Züblin for about €70 million. It will cover about 8,000 square meters (86,000 square feet) and host 15 operating rooms, a 71-bed intensive care ward and a central emergency department.

The price increase for hospital services in Germany has been set at 2.50% for 2017. This is in line with the level of past years.

Construction has begun at the HELIOS hospital in Hildesheim, a city in the German state of Lower Saxony, on a fourth hospital block. The nearly 6,000-square-meter (65,000 square feet), three-story building will house wards for ear, nose and throat medicine, oral-facial, and thoracic surgery. A pulmonary clinic acquired in 2014, currently situated in nearby Diekholzen, will be relocated to the new building including a sleep lab twice as large as the existing one. HELIOS is investing about €13 million in the new block of wards. Completion is expected in 2018.

Following Fresenius’ announcement to acquire the largest Spanish hospital operator Quirónsalud, the rating agencies Standard & Poor’s (BBB-, stable), Moody’s (Baa3, stable) and Fitch (BBB-, stable) are affirming the corporate credit ratings of Fresenius.